See All Slides - tctmd.com

Slides

Presentation TCT 2013

Antegrade Complications: The Not so Bad, the Truly Bad and the Ugly

Presenter: Scott Harding

October 28, 2013

Presentation TCT 2013

TransCardiac Therapeutics MitraFlex (Edge to Edge)

Presenter: Omar Lattouf

October 28, 2013

Presentation TCT 2013

St. Jude Medical Percutaneous Mitral Repair Device (Plication)

Presenter: Francis Wells

October 28, 2013

Presentation TCT 2013

Differential Diagnosis of Lower Extremity Ulcers

Presenter: Michael Jaff

October 28, 2013

Presentation TCT 2013

Does Transradial Intervention Increase the Risk of Stroke?

Presenter: James Nolan

October 28, 2013

Presentation TCT 2013

Not So Fast! Patient Oriented Outcomes Are Not So Different with New Technology: Most MVD Patients Benefit by CABG

Presenter: Vasim Farooq

October 28, 2013

Presentation TCT 2013

Are There Meaningful Clinical Differences between Different DES in Left Main Bifurcation and Non-bifurcation Lesions? The ISAR Left Main Trials and Other Data

Presenter: Adnan Kastrati

October 28, 2013

Presentation TCT 2013

Early Clinical Results Using the InSeal Trans-femoral Vascular Closure Device

Presenter: Nicolas van Mieghem

October 28, 2013

Presentation TCT 2013

Keynote Lecture: The Digital Health Ecosystem - Modulating Medical Innovation and Healthcare Efficiency

Presenter: Peter Fitzgerald

October 28, 2013

Presentation TCT 2013

Yes! With Current DES and Pharmacotherapy, SYNTAX Is Already Obsolete and the Majority of Patients with MVD Can Be Managed with PCI

Presenter: Dean Kereiakes

October 28, 2013

Advertisement

Slides

Antegrade Complications: The Not so Bad, the Truly Bad and the Ugly

TransCardiac Therapeutics MitraFlex (Edge to Edge)

St. Jude Medical Percutaneous Mitral Repair Device (Plication)

Differential Diagnosis of Lower Extremity Ulcers

Does Transradial Intervention Increase the Risk of Stroke?

Not So Fast! Patient Oriented Outcomes Are Not So Different with New Technology: Most MVD Patients Benefit by CABG

Are There Meaningful Clinical Differences between Different DES in Left Main Bifurcation and Non-bifurcation Lesions? The ISAR Left Main Trials and Other Data

Early Clinical Results Using the InSeal Trans-femoral Vascular Closure Device

Keynote Lecture: The Digital Health Ecosystem - Modulating Medical Innovation and Healthcare Efficiency

Yes! With Current DES and Pharmacotherapy, SYNTAX Is Already Obsolete and the Majority of Patients with MVD Can Be Managed with PCI

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content